Literature DB >> 28084714

Uterine Fibroids: Diagnosis and Treatment.

Maria Syl D De La Cruz1, Edward M Buchanan1.   

Abstract

Uterine fibroids are common benign neoplasms, with a higher prevalence in older women and in those of African descent. Many are discovered incidentally on clinical examination or imaging in asymptomatic women. Fibroids can cause abnormal uterine bleeding, pelvic pressure, bowel dysfunction, urinary frequency and urgency, urinary retention, low back pain, constipation, and dyspareunia. Ultrasonography is the preferred initial imaging modality. Expectant management is recommended for asymptomatic patients because most fibroids decrease in size during menopause. Management should be tailored to the size and location of fibroids; the patient's age, symptoms, desire to maintain fertility, and access to treatment; and the experience of the physician. Medical therapy to reduce heavy menstrual bleeding includes hormonal contraceptives, tranexamic acid, and nonsteroidal anti-inflammatory drugs. Gonadotropin-releasing hormone agonists or selective progesterone receptor modulators are an option for patients who need symptom relief preoperatively or who are approaching menopause. Surgical treatment includes hysterectomy, myomectomy, uterine artery embolization, and magnetic resonance-guided focused ultrasound surgery.

Entities:  

Mesh:

Year:  2017        PMID: 28084714

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  28 in total

1.  Estimating Uterine Fibroid SNP-Based Heritability in European American Women with Imaging-Confirmed Fibroids.

Authors:  Michael J Bray; Lea K Davis; Eric S Torstenson; Sarah H Jones; Todd L Edwards; Digna R Velez Edwards
Journal:  Hum Hered       Date:  2019-09-03       Impact factor: 0.444

2.  A Video Article: The Laparoscopic Uterine Artery Occlusion in Combination with Myomectomy for Uterine Myoma.

Authors:  Guihai Ai; Wei Huang; Weihong Yang; Jie Liu; Ning Luo; Jing Guo; Zhongping Cheng
Journal:  Gynecol Minim Invasive Ther       Date:  2022-05-04

Review 3.  Epigenomic and enhancer dysregulation in uterine leiomyomas.

Authors:  Oliwia W Mlodawska; Priyanka Saini; J Brandon Parker; Jian-Jun Wei; Serdar E Bulun; Melissa A Simon; Debabrata Chakravarti
Journal:  Hum Reprod Update       Date:  2022-06-30       Impact factor: 17.179

4.  Effects of total laparoscopic hysterectomy on the clinical outcomes of patients with uterine fibroids.

Authors:  Lang Zheng; Dan Liu; Chunyan Hu
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

5.  Health Care Costs and Treatment Patterns Associated with Uterine Fibroids and Heavy Menstrual Bleeding: A Claims Analysis.

Authors:  Alice Wang; Siting Wang; Charlotte D Owens; Jamie B Vora; Michael P Diamond
Journal:  J Womens Health (Larchmt)       Date:  2021-09-30       Impact factor: 3.017

6.  Esmolol Infusion Reduces Blood Loss and Opiate Consumption during Fertility Preserving Myomectomy.

Authors:  Jehan Mohammad Ezzat Hamed; Walid Mamdouh Ataalla
Journal:  Anesth Essays Res       Date:  2019 Jul-Sep

7.  Alterations in lipid profile upon uterine fibroids and its recurrence.

Authors:  Narine M Tonoyan; Vitaliy V Chagovets; Natalia L Starodubtseva; Alisa O Tokareva; Konstantin Chingin; Irena F Kozachenko; Leyla V Adamyan; Vladimir E Frankevich
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

8.  Red degeneration of a large leiomyoma in a non-pregnant woman in pursuit of 17 pregnancies: a case report.

Authors:  Dema Adwan; Sami Jomaa
Journal:  J Surg Case Rep       Date:  2021-07-15

9.  Educational Case: Smooth Muscle Tumors of the Uterus.

Authors:  Xiomara Brioso Rubio; Stacy G Beal; Julia A Ross; Jesse Kresak
Journal:  Acad Pathol       Date:  2020-06-19

10.  Association between tumor necrosis factor α and uterine fibroids: A protocol of systematic review.

Authors:  Li-Nan Gao; Lian-Gang Ge; Ming-Zhe Zhu; Xin-Xin Yao
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.